导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 16.57% | 232/1050 |
| 近一周 | -4.82% | 1054/1104 |
| 近一月 | -2.57% | 288/1102 |
| 近一季 | -1.83% | 319/1092 |
| 近半年 | - | 418/1070 |
| 近一年 | 31.09% | 152/1018 |
| 近两年 | 79.88% | 288/926 |
| 近三年 | 56.32% | 217/834 |
| 成立以来 | 210.30% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
6.72% 94/1070 |
5.53% 612/1101 |
- - |
- - |
| 2025 | 34.85% 400/1065 |
-2.03% 912/1014 |
2.02% 506/1038 |
23.97% 479/1050 |
8.83% 59/1065 |
| 2024 | 6.65% 373/1011 |
4.21% 125/960 |
0.47% 273/983 |
6.14% 854/991 |
-4.04% 597/1011 |
| 2023 | -9.13% 304/952 |
4.47% 351/880 |
-5.26% 543/895 |
-2.83% 196/915 |
-5.51% 562/952 |
| 2022 | -20.99% 368/867 |
-14.74% 248/773 |
5.05% 521/806 |
-11.48% 344/845 |
-0.34% 458/867 |
| 2021 | 12.48% 212/740 |
-2.44% 240/580 |
9.12% 383/659 |
2.38% 180/704 |
3.20% 294/740 |
| 2020 | 82.63% 82/554 |
-6.37% 328/419 |
25.70% 185/466 |
16.86% 110/517 |
32.79% 31/554 |
| 2019 | 38.06% 233/410 |
21.45% 888/1149 |
1.81% 180/1231 |
3.65% 227/390 |
7.73% 249/410 |
| 2018 | -19.70% 70/349 |
- - |
- - |
- - |
-11.06% 394/1080 |
| 2017 | 28.49% 46/285 |
- - |
- - |
- - |
- - |
| 2016 | -15.77% 97/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 工银国企改革股票 VS. 东吴新产业精选股票A(580008) |